SAN FRANCISCO, June 27, 2024 (Newswire.com) - Form Bio, the provider of advanced computational life sciences technology and PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate ...
Partnership leverages AI-powered genome design to optimize AAV constructs, accelerate lead candidate selection, and improve drug substance manufacturability for rare and ultra-rare neuromuscular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results